Carriage of methicillin-resistant Staphylococcus pseudintermedius in dogs--a longitudinal study

Ulrika Windahl1, Elin Reimegård, Bodil Ström Holst

  • 1Department of Animal Health and Antimicrobial Strategies, National Veterinary Institute, Uppsala, Sweden. ulrika.windahl@sva.se

Abstract

Insights

Dogs can carry methicillin-resistant Staphylococcus pseudintermedius (MRSP) for over a year post-infection. Prolonged MRSP carriage in dogs is linked to lengthy antimicrobial treatments, and specific sampling sites are more effective for detection.

Area of Science:

  • Veterinary Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Methicillin-resistant Staphylococcus pseudintermedius (MRSP) is an emerging pathogen in canine bacterial infections.
  • Understanding MRSP carriage duration and influencing factors is crucial for infection control.

Purpose of the Study:

  • To determine the duration of MRSP carriage in dogs following clinical infection.
  • To investigate factors influencing MRSP carriage length, including antimicrobial treatment, skin disease, and wound presence.
  • To evaluate optimal sampling strategies for MRSP detection.

Main Methods:

  • Longitudinal study of 31 dogs with prior clinical MRSP infection.
  • Repeated sampling from five body locations for a minimum of eight months or until two consecutive negative results.
  • Analysis of medical records and questionnaires for treatment and clinical data.

Main Results:

  • Median MRSP carriage duration was 11 months (48 weeks).
  • Systemic antimicrobial treatment (≥3 weeks) to which MRSP was resistant prolonged carriage.
  • Wound sites yielded the highest MRSP detection rate (81%); nostril cultures were least effective.

Conclusions:

  • Dogs can remain MRSP carriers for over a year post-infection.
  • Avoiding systemic antimicrobials to which MRSP is resistant may reduce carriage duration.
  • Recommended sampling sites for MRSP screening include pharynx, perineum, mouth corners, and wounds.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...